Citi upgrades Genentech (NYSE: DNA) from Hold to Buy. Price target lowered to $96.

Citi analyst says, "DNA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE